Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1985 1
1987 1
1988 1
1989 2
1991 2
1992 1
1993 3
1994 2
1995 4
1996 1
1997 4
1999 4
2000 2
2001 4
2002 3
2003 1
2004 3
2006 5
2007 2
2009 2
2010 4
2012 5
2013 1
2014 3
2015 2
2016 1
2017 2
2018 2
2019 4
2020 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
"Lowe syndrome: A particularly severe phenotype without clinical kidney involvement".
Abdalla E, El-Beheiry A, Dieterich K, Thevenon J, Fauré J, Rendu J. Abdalla E, et al. Am J Med Genet A. 2018 Feb;176(2):460-464. doi: 10.1002/ajmg.a.38572. Epub 2017 Dec 11. Am J Med Genet A. 2018. PMID: 29226564
Lowe syndrome (LS) is a very rare disorder of phosphatidylinositol metabolism, which manifests with a complex phenotype comprising a clinical triad encompassing major abnormalities of the eyes, the kidneys, and the central nervous system. ...Direct sequencing of the OCRL g …
Lowe syndrome (LS) is a very rare disorder of phosphatidylinositol metabolism, which manifests with a complex phenotype comprising a …
Discovery of a minimal form of RNase P in Pyrobaculum.
Lai LB, Chan PP, Cozen AE, Bernick DL, Brown JW, Gopalan V, Lowe TM. Lai LB, et al. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22493-8. doi: 10.1073/pnas.1013969107. Epub 2010 Dec 6. Proc Natl Acad Sci U S A. 2010. PMID: 21135215 Free PMC article.
RNase P RNA is an ancient, nearly universal feature of life. As part of the ribonucleoprotein RNase P complex, the RNA component catalyzes essential removal of 5' leaders in pre-tRNAs. ...A recent study concluded that N. equitans does not have or require RNase P …
RNase P RNA is an ancient, nearly universal feature of life. As part of the ribonucleoprotein RNase P complex, the RNA compone …
The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
Zhang X, Jefferson AB, Auethavekiat V, Majerus PW. Zhang X, et al. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4853-6. doi: 10.1073/pnas.92.11.4853. Proc Natl Acad Sci U S A. 1995. PMID: 7761412 Free PMC article.
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene. ...Deficiency of this enzyme apparently causes the protean manifestations of Lowe syndrome....
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene. ...Deficiency …
Hormone therapy and skeletal muscle strength: a meta-analysis.
Greising SM, Baltgalvis KA, Lowe DA, Warren GL. Greising SM, et al. J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1071-81. doi: 10.1093/gerona/glp082. Epub 2009 Jun 26. J Gerontol A Biol Sci Med Sci. 2009. PMID: 19561145 Free PMC article.
RESULTS: HT was found to result in a small beneficial effect on muscle strength in postmenopausal women (overall ES = 0.23; p = .003) that equated to an approximately 5% greater strength for women on HT. Among the 23 studies, various muscle groups were assessed for strengt …
RESULTS: HT was found to result in a small beneficial effect on muscle strength in postmenopausal women (overall ES = 0.23; p = .003) …
The essential gene set of a photosynthetic organism.
Rubin BE, Wetmore KM, Price MN, Diamond S, Shultzaberger RK, Lowe LC, Curtin G, Arkin AP, Deutschbauer A, Golden SS. Rubin BE, et al. Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):E6634-43. doi: 10.1073/pnas.1519220112. Epub 2015 Oct 27. Proc Natl Acad Sci U S A. 2015. PMID: 26508635 Free PMC article.
Similarity in transgender and cisgender children's gender development.
Gülgöz S, Glazier JJ, Enright EA, Alonso DJ, Durwood LJ, Fast AA, Lowe R, Ji C, Heer J, Martin CL, Olson KR. Gülgöz S, et al. Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24480-24485. doi: 10.1073/pnas.1909367116. Epub 2019 Nov 18. Proc Natl Acad Sci U S A. 2019. PMID: 31740598 Free PMC article.
Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
Snider RM, Longo KP, Drozda SE, Lowe JA 3rd, Leeman SE. Snider RM, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10042-4. doi: 10.1073/pnas.88.22.10042. Proc Natl Acad Sci U S A. 1991. PMID: 1719543 Free PMC article.
CP-96,345 [(2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl) methyl]-1-azabicyclo[2.2.2]octan-3-amine) antagonism of substance P-stimulated salivation was investigated in pentobarbital-anesthetized rats. Administered either intraperitoneally or orally, CP-96,345 produced …
CP-96,345 [(2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl) methyl]-1-azabicyclo[2.2.2]octan-3-amine) antagonism of substance P-st …
76 results